Galera Therapeutics (GRTX) Stock Chart & Stock Price History $0.03 +0.00 (+13.08%) As of 07/3/2025 11:58 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Galera Therapeutics Stock Price Performance The Galera Therapeutics (GRTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 78.71%, with a year-to-date return of -35.81%. In the past month, the stock has increased 24.58%, reflecting recent market activity. As of the latest close, Galera Therapeutics traded at $0.03 with a market cap of $2.22 million and volume of 2,164 shares. Five years ago, the stock traded at $7.21, representing a 99.59% decrease over that period. At the time, it had a market cap of $177.25 million and a volume of 37,539 shares. Receive GRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.16%1 Month Performance+24.58%3 Month Performance+17.60%Year-To-Date Performance-35.81%1 Year Performance-78.71%5 Year Performance-99.59% GRTX Stock Chart for Friday, July, 4, 2025 GRTX Chart by TradingView Galera Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$0.03$0.03$0.03$0.032,164 shs$2.22 million07/03/2025$0.03$0.03+13.08%$0.03$0.032,164 shs$2.22 million07/02/2025$0.03$0.03$0.03$0.0389,589 shs$1.96 million07/01/2025$0.03$0.03-4.41%$0.03$0.0389,589 shs$1.96 million06/30/2025$0.03$0.03-4.56%$0.03$0.03374 shs$2.05 million06/27/2025$0.03$0.03-1.72%$0.03$0.0328,426 shs$2.15 million06/26/2025$0.03$0.03+1.75%$0.03$0.0343,224 shs$2.19 million06/25/2025$0.03$0.03-1.72%$0.03$0.0318,317 shs$2.15 million06/24/2025$0.03$0.03+4.69%$0.03$0.0325,211 shs$2.19 million06/23/2025$0.03$0.03-1.07%$0.03$0.0347,689 shs$2.09 million Get the Latest News and Ratings for GRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$0.03$0.03$0.03$0.037,535 shs$2.11 million06/19/2025$0.03$0.03$0.03$0.033,953 shs$2.11 million06/18/2025$0.03$0.03$0.03$0.033,953 shs$2.11 million06/17/2025$0.03$0.03-3.45%$0.03$0.0366,351 shs$2.11 million06/16/2025$0.03$0.03+7.41%$0.03$0.033,107 shs$2.19 million06/13/2025$0.03$0.03-17.18%$0.04$0.03220,425 shs$2.04 million06/12/2025$0.03$0.03+18.55%$0.04$0.03187,982 shs$2.46 million06/11/2025$0.02$0.03+16.03%$0.03$0.0359,103 shs$2.08 million06/10/2025$0.02$0.02-0.42%$0.03$0.0222,181 shs$1.79 million06/09/2025$0.02$0.02+0.42%$0.02$0.0224,408 shs$1.80 million06/06/2025$0.02$0.02$0.02$0.0228,334 shs$1.79 million06/05/2025$0.02$0.02+0.42%$0.03$0.0246,626 shs$1.79 million06/04/2025$0.03$0.02-8.88%$0.03$0.0264,285 shs$1.78 million06/03/2025$0.03$0.03+1.97%$0.03$0.025,001 shs$1.95 million Related Companies CYCC Stock Chart TCRT Stock Chart PMCB Stock Chart CLDI Stock Chart ORGS Stock Chart APLM Stock Chart SLXN Stock Chart AIM Stock Chart OMGA Stock Chart CELZ Stock Chart Receive GRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GRTX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRTX Stock Alerts